Perspective Therapeutics, Inc. — Director's Dealing 2025

Sep 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2025-09-04

Reporting Person: Sendek Joel (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-04	Stock option (right to buy)	$3.54	A	600000	Acquired	2035-09-04	Common Stock (600000)	Direct

Footnotes

F1: The options vest over a four-year period, with one-fourth (1/4) vesting and becoming exercisable on September 4, 2026, and the remaining options vesting and becoming exercisable ratably over the following 36 months, subject to the continuous service of the Reporting Person as of each vesting date.